Saad Harti
Founder & Chief Executive Officier
Switzerland
Saad has started in the financial field, at Arthur Andersen.He later co-founded Altacare, a healthcare business development firm active in more than 50 markets Saad has pioneered contraceptive-access programs in developing countries. Saad is the founder of Legacy and manages the company.

Jiawei Liu PhD
Head of Research
Switzerland
Dr. JiaWei Liu, PhD is an expert in the molecular biology and dermatology, with over 20 years’ preclinical and clinical research and teaching experience at high ranking academic institutes (Universities and Hospitals Geneva, Lausanne, Harvard Medical School, Shanghai Institute of Materia Medica) and pharmaceutical companies (Debiopharm and Astellas).

Michel Chrétienne PharmD
Head of Production
France
Michel Chrétienne, PharmD is member of the French Academy of Pharmacy. He spent 30 years as Pharmaceutical Director at Roussel (now Sanofi). He then spent more than 10 years at HRA Pharma, a specialty pharma, as Qualified person in charge of Quality System and batch release.

Nadine Vincent PharmD
Regulatory
France
Dr. Nadine Vincent, PharmD is a pharmacist with 40 years’ experience in Regulatory Affairs at large pharma and medium-sized biotechs. Nadine has contributed to achieving FDA and EMA approval for 6 drugs.

Alexandre Guichard
Clinical
Switzerland
Dr. Alexandre Guichard, PharmD, Ph D is an expert in dermatology, having participated in several clinical trials focusing on scalp disorders. Prior to Legacy Healthcare, Dr. Guichard was the manager and founder of the Trichology Unit at Besançon University Hospital (FR)

Cécile Bernier
Formulation
Switzerland
Cécile Bernier is an expert in formulation and manufacturing, and has over 10 years’ experience in developing formulation She oversaw already the manufacturing of 100 industrial batches of Coacillium during pre-marketing period

Marcos Val
CFO
Switzerland
Marcos spent 15 years in Healthcare and FMCG blue-chip corporates. Within biopharma, as Medtronic director, he did launch multi-million revenue programs. He later built a track-record raising funds for startups and carrying due diligence work for investors, until joining Legacy in 2017.

Tadafumi Shiiba
Japan operations
Japan

Tadafumi Shiiba, General Manager for Legacy Healthcare KK (Japan), has been working for medical corporations for more than 20 years with experiencing to manage two clinical trials on the product in Japan

Amit Srivastava
India operations
India

Amit Srivastava is a pharmacist and MBA with over 25 years’ experience in business management with large pharmaceuticals and nutraceuticals companies at C’ suite level. Amit has also set up world’s first and largest biotech and nutratech start up incubation hub for government of India as director on board and CEO.

Saad Harti
Founder & Chairman
Switzerland
Saad has started in the financial field, at Arthur Andersen.He later co-founded Altacare, a healthcare business development firm active in more than 50 markets. Saad has pioneered contraceptive-access programs in developing countries.Saad is the founder of Legacy and manages the company.

Geert Cauwenbergh PhD
Co-founder, Director
US
Geert founded Barrier Therapeutics, a dermatology company in 2001. After bringing Barrier to success it was acquired by Stiefel in 2008. Prior to founding Barrier, Geert was responsible for the worldwide research and development of all skin care products for the Johnson & Johnson consumer companies. He is a board member of several dermatology companies. He has authored more than 100 publications.

Johanne Barthelet
Director
Johanne started as a consultant, including with PWC Transaction Services division. She took-over and successfully turned-around a Swiss specialty-logistics and international transport company

Bernard Lignon
Director
Bernard started his career in pharma sales and marketing. He managed the European and African affiliates of several pharmaceutical firms (Sanofi, Akzo, etc.). He has been in charge of the communication of Pierre Fabre, one the largest independent European pharma, and a pioneer of botanical-based treatment and oncology.

Michel Chrétienne PharmD
Director
Michel Chrétienne, PharmD is member of the French Academy of Pharmacy. He spent 30 years as Pharmaceutical Director at Roussel (now Sanofi).

Dr. med. Ulrike Blume-Peytavi
Germany
Investigator
Clinical Research Centre for Hair and Skin Science Charité-Universitätsmedizin
Our collaboration with Dr. Blume-Peytavi on ClinicalTrials.gov
Profile

Juhee Cho,PhD
Investigator
Korea
Investigator for Permanent Chemotherapy-Induced Alopecia
Our collaboration with Dr. Cho on ClinicalTrials.gov
Profile

Dr. Khalil Zaman
Investigator
Switzerland
CHUV- Investigator for Chemotherapy-Induced Alopecia
Our collaboration with Dr. Zaman on ClinicalTrials.gov
Profile

Prof. Bianca Maria Piraccini
Investigator
Italy
University of Bologna Dermatology Department of Specialized, Experimental and Diagnostic Medicine
Our collaboration with Dr. Blume-Peytavi on ClinicalTrials.gov
Profile

Dr. Leorey N. Saligan
Investigator
US
Maryland, US National Institutes of Health
Investigator for Cancer-Related Fatigue
Profile

Yasuyuki Kojima, MD, PhD
Investigator
Japan
St Marianna University School of Medicine
Investigator for Chemotherapy-Induced Alopecia trial Our collaboration with Dr. Kojima on UMIN
Profile

Pr.William Pralong, MD PhD
Advisor
Switzerland
Prof. em. EPLF, Bioengineering, QAQC
Scientific Advisor for Quality and Research
Profile

Pr. Kurt Hostettman
Advisor
Switzerland
Prof.em. UniGe and Unil, Pharmacy
Scientific Advisor for development of New Botanical Entities
Profile

Dr Liliane Laroche
Advisor
France
Michel has served as Pharmaceutical Director and Pharmacist in charge at Hoechst Marion Roussel (Aventis) until 1999. Michel is involved in a number of professional and scientific societies such as the French Association of Regulatory Affairs, Member of the Ethic Committee and Mediation of the French pharmaceutical industry (CEMIP) etc. Michel is responsible of the quality and manufacturing affairs of Legacy.

Bruce Patsner MD, JD
Medical
US
Bruce Patsner M.D. J.D. is a cancer surgeon, law Professor and former Senior Medical Officer at FDA with more than 15 years Pharma experience in clinical trial design, new prescription drug approval and pharmacovigilance, and regulation of drugs, devices, and biologics. While at FDA he was responsible for the approval of several new prescription drugs in women’s health and Oncology and reviewed more than 50 INDs. He is also a current member of the Editorial Board of the prestigious law journal Food and Drug Law.
Bruce is supporting Legacy Healthcare work friendly.